TMO · 10-Q · 2026Q3 · Full report

Share Repurchase Program

THERMO FISHER SCIENTIFIC INC. · 2026-10-30 · Importance 52 · Surprise 56

The company repurchased $4.00 billion of common stock, or 6.9 million shares, in the first nine months of 2026, compared with $3.00 billion, or 5.8 million shares, in the prior-year period. All 2026 repurchases were under the Board’s November 6, 2025 authorization for up to $5.00 billion. At October 30, 2026, $1.00 billion remained available under that authorization. The company also paid $0.51 billion in cash dividends during the first nine months of 2026, compared with $0.47 billion in 2025.

Key facts

• In the first nine months of 2026, Thermo Fisher Scientific Inc. repurchased $4.00 billion of common stock, or 6.9 million shares. source
• In the first nine months of 2025, Thermo Fisher Scientific Inc. repurchased $3.00 billion of common stock, or 5.8 million shares, of which $0.04 billion settled in the fourth quarter of 2025. source
• On November 6, 2025, Thermo Fisher Scientific Inc.’s Board of Directors authorized repurchases of up to $5.00 billion of the company’s common stock. source
• Thermo Fisher Scientific Inc. had $1.00 billion available for future share repurchases under the authorization at October 30, 2026. source
• Thermo Fisher Scientific Inc.’s weighted average diluted shares decreased in 2026 compared with 2025, primarily due to share repurchases, net of option dilution. source
• All Thermo Fisher Scientific Inc. common shares repurchased during the first nine months of 2026 were under the November 6, 2025 program. source